137 related articles for article (PubMed ID: 23842831)
21. Regarding "an analysis of relationship between quality of life indices and clinical improvement following intervention in patients with intermittent claudication due to femoropopliteal disease".
Frans FA; Koelemay MJ
J Vasc Surg; 2011 Apr; 53(4):1164; author reply 1164. PubMed ID: 21439465
[No Abstract] [Full Text] [Related]
22. Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training--randomized controlled trial.
Spronk S; Bosch JL; den Hoed PT; Veen HF; Pattynama PM; Hunink MG
Radiology; 2009 Feb; 250(2):586-95. PubMed ID: 19188327
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of revascularization in patients with intermittent claudication.
Djerf H; Falkenberg M; Jivegård L; Lindgren H; Svensson M; Nordanstig J
Br J Surg; 2018 Dec; 105(13):1742-1748. PubMed ID: 30357819
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial.
Reynolds MR; Apruzzese P; Galper BZ; Murphy TP; Hirsch AT; Cutlip DE; Mohler ER; Regensteiner JG; Cohen DJ
J Am Heart Assoc; 2014 Nov; 3(6):e001233. PubMed ID: 25389284
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of superficial femoral artery endovascular interventions in the UK and Germany: a modelling study.
Kearns BC; Thomas SM
BMJ Open; 2017 Jan; 7(1):e013460. PubMed ID: 28087551
[TBL] [Abstract][Full Text] [Related]
26. Value of information analyses of economic randomized controlled trials: the treatment of intermittent claudication.
Groot Koerkamp B; Spronk S; Stijnen T; Hunink MG
Value Health; 2010; 13(2):242-50. PubMed ID: 19818058
[TBL] [Abstract][Full Text] [Related]
27. Editor's Choice - Cost Effectiveness of Primary Stenting in the Superficial Femoral Artery for Intermittent Claudication: Two Year Results of a Randomised Multicentre Trial.
Djerf H; Svensson M; Nordanstig J; Gottsäter A; Falkenberg M; Lindgren H
Eur J Vasc Endovasc Surg; 2021 Oct; 62(4):576-582. PubMed ID: 34454817
[TBL] [Abstract][Full Text] [Related]
28. Pretreatment imaging workup for patients with intermittent claudication: a cost-effectiveness analysis.
Visser K; Kuntz KM; Donaldson MC; Gazelle GS; Hunink MG
J Vasc Interv Radiol; 2003 Jan; 14(1):53-62. PubMed ID: 12525586
[TBL] [Abstract][Full Text] [Related]
29. In-hospital costs of self-expanding nitinol stent implantation versus balloon angioplasty in the femoropopliteal artery (the VascuCoil Trial).
Greenberg D; Rosenfield K; Garcia LA; Berezin RH; Lavelle T; Fogleman S; Cohen DJ
J Vasc Interv Radiol; 2004 Oct; 15(10):1065-9. PubMed ID: 15466792
[TBL] [Abstract][Full Text] [Related]
30. Trials of endovascular treatment for superficial femoral artery occlusive lesions: a call for medically managed control patients.
Wilson SE
Ann Vasc Surg; 2010 May; 24(4):498-502. PubMed ID: 20036508
[TBL] [Abstract][Full Text] [Related]
31. United Kingdom back pain exercise and manipulation (UK BEAM) randomised trial: cost effectiveness of physical treatments for back pain in primary care.
UK BEAM Trial Team
BMJ; 2004 Dec; 329(7479):1381. PubMed ID: 15556954
[TBL] [Abstract][Full Text] [Related]
32. Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial.
Kakkos SK; Geroulakos G; Nicolaides AN
Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):164-75. PubMed ID: 15890545
[TBL] [Abstract][Full Text] [Related]
33. In-hospital outcomes and cost comparison of femoropopliteal reopening strategies.
Safley DM; Lindsey JB; Robertus K; House JA; Mahoney E; Allen KB; Cohen DJ
Cardiovasc Revasc Med; 2011; 12(5):292-8. PubMed ID: 21273148
[TBL] [Abstract][Full Text] [Related]
34. Does percutaneous transluminal angioplasty improve quality of life?
Keeling AN; Naughton PA; O'Connell A; Lee MJ
J Vasc Interv Radiol; 2008 Feb; 19(2 Pt 1):169-76. PubMed ID: 18341944
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of diagnostic imaging work-up and treatment for patients with intermittent claudication in The Netherlands.
Visser K; de Vries SO; Kitslaar PJ; van Engelshoven JM; Hunink MG
Eur J Vasc Endovasc Surg; 2003 Mar; 25(3):213-23. PubMed ID: 12623332
[TBL] [Abstract][Full Text] [Related]
36. Plasma tissue factor is a predictor for restenosis after femoropopliteal angioplasty.
Ray B; Chetter IC; Lee HL; Ettelaie C; McCollum PT
Br J Surg; 2007 Sep; 94(9):1092-5. PubMed ID: 17497755
[TBL] [Abstract][Full Text] [Related]
37. The cost-effectiveness of supervised exercise for the treatment of intermittent claudication.
Bermingham SL; Sparrow K; Mullis R; Fox M; Shearman C; Bradbury A; Michaels J
Eur J Vasc Endovasc Surg; 2013 Dec; 46(6):707-14. PubMed ID: 24103792
[TBL] [Abstract][Full Text] [Related]
38. Design of the multicenter standardized supervised exercise training intervention for the claudication: exercise vs endoluminal revascularization (CLEVER) study.
Bronas UG; Hirsch AT; Murphy T; Badenhop D; Collins TC; Ehrman JK; Ershow AG; Lewis B; Treat-Jacobson DJ; Walsh ME; Oldenburg N; Regensteiner JG;
Vasc Med; 2009 Nov; 14(4):313-21. PubMed ID: 19808716
[TBL] [Abstract][Full Text] [Related]
39. Percutaneous transluminal angioplasty (PTA) alone versus PTA with balloon-expandable stent placement for short-segment femoropopliteal artery disease: a metaanalysis of randomized trials.
E Y; He N; Wang Y; Fan H
J Vasc Interv Radiol; 2008 Apr; 19(4):499-503. PubMed ID: 18375292
[TBL] [Abstract][Full Text] [Related]
40. Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery by noninvasive magnetic resonance imaging.
Wyttenbach R; Gallino A; Alerci M; Mahler F; Cozzi L; Di Valentino M; Badimon JJ; Fuster V; Corti R
Circulation; 2004 Aug; 110(9):1156-61. PubMed ID: 15326071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
